Revenue growth remains important, but investors are now watching the quality of that growth more closely
High medication costs remain a significant barrier, with the average price of GLP-1 drugs reaching USD 1,200 per month, making them inaccessible to many
Healthcare Financial Management, 77 (4), 52-60
PubMed laboratory research record [PMID: 39955112] PubMed record related to this compound for laboratory literature review
Clinical Guidelines and Practice Implications Current healthcare policies often create obstacles for patients who need timely anti-obesity medication (AOM) intervention
By rewarding spending with emotionally appealing gifts, they protected their brand value while creating a shopping experience that felt exciting and rewarding